Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease
Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease
Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease